Showing results (131-140 of 143) with videos related to
Sort By:
Pageof 15
ESMO Open|May 23, 2021
The EMA assessment of avapritinib in the treatment of gastrointestinal stromal tumours harbouring the PDGFRA D842V mutationA Trullas-Jimeno, J Delgado, B Garcia-Ochoa, et al.Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 21, 2006
Highly preferential association of NonF508del CF mutations with the M470 alleleB M Ciminelli, A Bonizzato, C Bombieri, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 12, 2002
Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patientsC H Köhne, D Cunningham, F Di Costanzo, et al.Clinical and Experimental Medicine|June 2, 2005
Interaction between metabolic syndrome and PON1 polymorphisms as a determinant of the risk of coronary artery diseaseN Martinelli, D Girelli, O Olivieri, et al.ESMO Open|March 4, 2023
Off-label despite high-level evidence: a clinical practice review of commonly used off-patent cancer medicinesG Zarkavelis, A L Amylidi, C Verbaanderd, et al.Clinical Pharmacology and Therapeutics|September 22, 2016
"Threshold-crossing": A Useful Way to Establish the Counterfactual in Clinical Trials?H-G Eichler, B Bloechl-Daum, P Bauer, et al.Human Genetics|April 4, 2000
A new approach for identifying non-pathogenic mutations. An analysis of the cystic fibrosis transmembrane regulator gene in normal individualsC Bombieri, S Giorgi, S Carles, et al.Clinical Pharmacology and Therapeutics|August 12, 2015
Structured Frameworks to Increase the Transparency of the Assessment of Benefits and Risks of Medicines: Current Status and Possible Future DirectionsF Pignatti, D Ashby, E P Brass, et al.American Journal of Human Genetics|June 1, 1996
X-linked Alport syndrome: an SSCP-based mutation survey over all 51 exons of the COL4A5 geneA Renieri, M Bruttini, L Galli, et al.Genomics|October 23, 1998
Asthma and bronchial hyperresponsiveness linked to the XY long arm pseudoautosomal regionK J Holroyd, L C Martinati, E Trabetti, et al.Pageof 15